Physician

Ying Du, M.D.

According to 2025 Medicare claims, Ying Du, M.D. (NPI: 1295725182) practices rheumatology in the St. Louis, MO-IL market, with the plurality of this provider's patient population coming from Madison, IL. This provider's primary affiliated billing organization is ST LOUIS MEDICAL CLINIC, P.C. (NPI: 1174505127; TIN: 430820801) and primary practice location at 63131-2322. Du is affiliated with the Aledade A2643 Primary Care MSSP Enhanced (ACO ID: A2643), participating under the MSSP model.

Du's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 275 traditional Medicare patients, billed 102,786 HCPCS/CPT codes, and received $1,526,826 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 4,856 prescription claims across 497 beneficiaries totaling $924,235 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 139 records totaling $2,303. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $75,899 to $1,526,826. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	317	1,938	$75,899
2016	347	1,640	$81,411
2017	336	1,051	$63,271
2018	328	8,429	$242,319
2019	320	21,302	$564,125
2020	363	38,169	$1,012,493
2021	340	51,833	$1,087,611
2022	308	63,241	$1,334,198
2023	299	92,774	$1,695,095
2024	275	102,786	$1,526,826

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	356	4,135	$701,222
2016	447	5,165	$846,389
2017	485	4,712	$988,835
2018	465	3,982	$984,996
2019	345	3,860	$783,312
2020	419	4,669	$878,126
2021	439	4,854	$985,837
2022	442	4,610	$793,222
2023	467	4,511	$705,501
2024	497	4,856	$924,235

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	38	38	$112
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	267	758	$83
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	72	455	$46
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	156	289	$12
36415	Insertion of needle into vein for collection of blood sample	70	85	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	26	728	$197,587
Rinvoq	Upadacitinib	22	660	$150,559
Humira(Cf) Pen	Adalimumab	21	588	$148,367
Taltz Autoinjector	Ixekizumab	11	308	$89,331
Xeljanz Xr	Tofacitinib Citrate	11	330	$62,603

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	139	$2,303	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ying Du, M.D.?

Tedicare shows public-source Medicare data for Ying Du, M.D. (NPI 1295725182), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ying Du, M.D. have ACO affiliation data?

Ying Du, M.D. is shown with ACO affiliation data for Aledade A2643 Primary Care MSSP Enhanced (MSSP, ACO ID A2643).

What billing organization is linked to Ying Du, M.D.?

Ying Du, M.D. is linked to ST LOUIS MEDICAL CLINIC, P.C. (billing NPI 1174505127) in the available physician profile data.

Does Ying Du, M.D. have Open Payments data?

Ying Du, M.D. has 139 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.